Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 0 | 317 | 2,080 |
| Cost of Goods | 0 | 0 | 0 | 158 | 1,153 |
| Gross Profit | 0 | 0 | 0 | 159 | 927 |
| Operating Expenses | 59,376 | 64,071 | 58,413 | 52,062 | 34,966 |
| Operating Income | -59,376 | -64,071 | -58,413 | -51,745 | -33,886 |
| Other Income | 3,351 | 3,035 | 4,941 | 1,231 | 43 |
| Pre-tax Income | -56,025 | -61,037 | -53,472 | -50,514 | -33,843 |
| Income Tax | N/A | N/A | N/A | N/A | -308 |
| Net Income Continuous | -56,025 | -61,037 | -53,472 | -50,514 | -33,536 |
| Net Income | $-56,025 | $-61,037 | $-53,472 | $-50,514 | $-33,536 |
| EPS Basic Total Ops | -1.27 | -2.04 | -1.88 | -1.91 | -2.46 |
| EPS Basic Continuous Ops | -1.27 | -2.04 | -1.88 | -1.91 | -2.46 |
| EPS Diluted Total Ops | -1.27 | -2.04 | -1.88 | -1.91 | -2.46 |
| EPS Diluted Continuous Ops | -1.27 | -2.04 | -1.88 | -1.91 | -2.46 |
| EPS Diluted Before Non-Recurring Items | -1.27 | -2.04 | -1.88 | -1.91 | -2.46 |
| EBITDA(a) | $-58,833 | $-63,617 | $-58,666 | $-51,120 | $-33,597 |